Page last updated: 2024-08-16

tibolone and Disease Exacerbation

tibolone has been researched along with Disease Exacerbation in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (50.00)	29.6817
2010's	1 (25.00)	24.3611
2020's	1 (25.00)	2.80

Authors

Authors	Studies
De Nicola, AF; Garay, LI; García Segura, LM; Lima, A; Mancino, DNJ; Roig, P	1
Hafezi, F; Hafezi, NL; Randleman, JB; Torres-Netto, EA	1
Anthony, MS; Clarkson, TB; Mikkola, TS; St Clair, RW	1
Bots, ML; Evans, GW; Grobbee, DE; Helmond, FA; McBride, KH; Meijer, R; Paskett, ED; Riley, W	1

Trials

1 trial(s) available for tibolone and Disease Exacerbation

Article	Year
The Osteoporosis Prevention and Arterial effects of tiboLone (OPAL) study: design and baseline characteristics. Controlled clinical trials, 2003, Volume: 24, Issue:6 Topics: Aged; Bone Density; Carotid Arteries; Disease Progression; Double-Blind Method; Estrogens, Conjugated (USP); Female; Humans; Middle Aged; Norpregnenes; Osteoporosis; Postmenopause; Random Allocation; Randomized Controlled Trials as Topic; Surveys and Questionnaires; Ultrasonography	2003

Article

Year

The Osteoporosis Prevention and Arterial effects of tiboLone (OPAL) study: design and baseline characteristics.

Controlled clinical trials, 2003, Volume: 24, Issue:6

Topics: Aged; Bone Density; Carotid Arteries; Disease Progression; Double-Blind Method; Estrogens, Conjugated (USP); Female; Humans; Middle Aged; Norpregnenes; Osteoporosis; Postmenopause; Random Allocation; Randomized Controlled Trials as Topic; Surveys and Questionnaires; Ultrasonography

2003

Other Studies

3 other study(ies) available for tibolone and Disease Exacerbation

Article	Year
Tibolone restrains neuroinflammation in mouse experimental autoimmune encephalomyelitis. Journal of neuroendocrinology, 2022, Volume: 34, Issue:1 Topics: Animals; Disease Models, Animal; Disease Progression; Encephalomyelitis, Autoimmune, Experimental; Female; Inflammation; Mice; Mice, Inbred C57BL; Neuritis; Neuroprotective Agents; Norpregnenes; Remission Induction	2022
Late-onset progression of keratoconus after therapy with selective tissue estrogenic activity regulator. Journal of cataract and refractive surgery, 2019, Volume: 45, Issue:1 Topics: Collagen; Corneal Stroma; Corneal Topography; Cross-Linking Reagents; Disease Progression; Endometriosis; Estrogen Receptor Modulators; Female; Humans; Keratoconus; Middle Aged; Norpregnenes; Ovariectomy; Photosensitizing Agents; Riboflavin; Ultraviolet Rays; Visual Acuity	2019
Comparison of tibolone and conjugated equine estrogens effects on carotid artery atherosclerosis of postmenopausal monkeys. Stroke, 2002, Volume: 33, Issue:11 Topics: Animals; Carotid Artery Diseases; Carotid Artery, Common; Carotid Artery, Internal; Cholesterol, HDL; Cholesterol, VLDL; Diet, Atherogenic; Disease Models, Animal; Disease Progression; Drug Therapy, Combination; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Lipoproteins, LDL; Macaca fascicularis; Medroxyprogesterone Acetate; Norpregnenes; Postmenopause; Time; Vascular Patency	2002